Company Filing History:
3 out of 3,685 
3 out of 45 
Years Active: 2019-2024
Title: Thomas Davis: Innovator in Cancer Treatment
Introduction
Thomas Davis is a notable inventor based in Centreville, MD (US), recognized for his contributions to cancer treatment. He holds 3 patents that focus on innovative methods for combating various types of cancer. His work has the potential to significantly impact the field of oncology.
Latest Patents
One of his latest patents involves the use of an anti-PD-1 antibody in combination with an anti-CD27 antibody for cancer treatment. This invention provides methods for treating cancer in a subject by administering both antibodies. In some embodiments, the cancer types targeted include colorectal cancer, rectal cancer, colon cancer, lung cancer, melanoma, ovarian cancer, head and neck cancer, or any combination thereof. This dual approach aims to enhance the effectiveness of cancer therapies.
Career Highlights
Throughout his career, Thomas Davis has worked with prominent companies in the pharmaceutical industry. He has been associated with Bristol-Myers Squibb Company and Celldex Therapeutics Limited, where he contributed to groundbreaking research and development in cancer therapies.
Collaborations
Thomas has collaborated with notable professionals in the field, including Vladimir Coric and Tibor P Keler. These collaborations have further enriched his research and innovation efforts.
Conclusion
Thomas Davis stands out as an influential inventor in the realm of cancer treatment, with a focus on innovative antibody therapies. His contributions are paving the way for advancements in oncology and improving patient outcomes.